Login / Signup

Closed-loop stimulation in periods with less epileptiform activity drives improved epilepsy outcomes.

Daria Nesterovich AndersonChantel M CharleboisElliot H SmithTyler S DavisAngela Y PetersBlake J NewmanAmir M ArainKaren S WilcoxChristopher R ButsonJohn D Rolston
Published in: Brain : a journal of neurology (2023)
In patients with drug-resistant epilepsy, electrical stimulation of the brain in response to epileptiform activity can make seizures less frequent and debilitating. This therapy, known as closed-loop responsive neurostimulation (RNS), aims to directly halt seizure activity via targeted stimulation of a burgeoning seizure. Rather than immediately stopping seizures as they start, many RNS implants produce slower, long-lasting changes in brain dynamics that better predict clinical outcomes. Here we hypothesize that stimulation during brain states with less epileptiform activity drives long-term changes that restore healthy brain networks. To test this, we quantified stimulation episodes during low- and high-risk brain states-that is, stimulation during periods with a lower or higher risk of generating epileptiform activity-in a cohort of 40 patients treated with RNS. More frequent stimulation in tonic low-risk states, and out of rhythmic high-risk states, predicted seizure reduction. Additionally, stimulation events were more likely to be phase-locked to prolonged episodes of abnormal activity for intermediate and poor responders when compared to super responders, consistent with the hypothesis that improved outcomes are driven by stimulation during low-risk states. These results support the hypothesis that stimulation during low-risk periods might underlie the mechanisms of RNS, suggesting a relationship between temporal patterns of neuromodulation and plasticity that facilitates long-term seizure reduction.
Keyphrases
  • drug resistant
  • white matter
  • resting state
  • temporal lobe epilepsy
  • cerebral ischemia
  • functional connectivity
  • stem cells
  • spinal cord injury
  • metabolic syndrome
  • glycemic control
  • subarachnoid hemorrhage